About V-Wave Medical
Our mission is improving clinical outcomes for heart failure patients by providing innovative interventional technologies.
V-Wave Ltd., was established in Israel in 2009 with a focus on developing a percutaneous implantable shunt for patients with chronic heart failure. Our leading product, the V-Wave Ventura Interatrial Shunt, is an investigational device that has received Breakthrough Device Designation from the FDA and CE Marking in the EU. Johnson & Johnson acquired V-Wave on October 9, 2024, and we are now proudly part of Johnson & Johnson MedTech.
V-Wave Management
Bill Abraham
Chief Medical Officer
Matt Borenzweig
Head of Commercial Strategy V-Wave
Debbie Deutsch
Head of Global Clinical Affairs V-Wave
Rebecca Doyle
HR Leader V-Wave
Matt Gaylord
VP General Manager V-Wave
Moran Levi
Israel GM and Global Head of Operations
Michael Mizrachi
Head of Quality & Compliance
Miki Polak
Finance Director Global V-Wave
Lydia Telep
Head of Global Regulatory Affairs V-Wave
